BELGRADE, Mont., April 6, 2015 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, is pleased to announce that the United States Patent and Trademark Office has issued US Patent No.

Related posts:

  1. Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge(R)SC
  2. Bacterin Announces Clinical Results on the Use of OsteoSponge(R) SC Allograft Published in The Journal of Foot & Ankle Surgery
  3. Bone Biologics Announces Major US Patent Issuances for Its Recombinant Protein Process
Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone